EN
HI
Aurobindo Pharma share price chart
Aurobindo Pharma Share Key Metrics
Volume
8.25 L
Market Cap
93332.05 CR
LTQ@LTP
61@1622.10
ATP
1635.93
Var Margin
14.41 %
Circuit Range
1497.1-1829.7
Delivery %
52.47 %
Value
134.94 CR
ASM/GSM
No
Market Lot
1
Summary
AUROPHARMA stock price is ₹1622.1 as of 14 Aug, 2026. The stock intraday movement has stayed between ₹1621.90 and ₹1670.00, while Aurobindo Pharma share price 52 week high low is ₹1016.10 & ₹1682.40.
In terms of trading activity, AUROPHARMA share price has recorded a volume of 8,24,842 shares. The Aurobindo Pharma has a market cap of ₹575377895. The stock’s Average Traded Price (ATP) stands at ₹1635.93, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 61 @ ₹1622.10.
The Aurobindo Pharma upper circuit limit is ₹1829.70 & The Aurobindo Pharma lower circuit limit is ₹1497.10, with a Value of ₹134.94 CR. The Delivery Percentage for the day is 52.47%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Aurobindo Pharma Fundamentals
P/E Ratio
25.67
P/B Ratio
2.45
Div. Yield
0.24
Sector P/E
64.91
Sector P/B
3.33
Sec. Div. Yield
0.51
Aurobindo Pharma Resistance and Support
Pivot 1666.77
Resistance
First Resistance
1679.04
Second Resistance
1694.67
Third Resistance
1706.94
Support
First Support
1651.14
Second Support
1638.87
Third Support
1623.24
Aurobindo Pharma Futures & Options
Aurobindo Pharma Option Chain
View Price, OI, Greeks & More...
25AUG26
1636.00
-29.60 (1.78%)
29SEP26
1650.70
-24.20 (1.44%)
27OCT26
1649.90
-30.10 (1.79%)
AUROPHARMA|25AUG26 CE 1620.00
37.10
-21.95 (-37.17%)
AUROPHARMA|25AUG26 PE 1640.00
30.25
10.2 (50.87%)
Aurobindo Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 14 2026 | 1662.4 | 1622.1 | -2.48% | 1670 | 1621.9 |
| Thu Aug 13 2026 | 1666 | 1663.4 | -0.22% | 1682.4 | 1654.5 |
| Wed Aug 12 2026 | 1658 | 1667 | 0.54% | 1667 | 1652.3 |
Aurobindo Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-21 | Audited Results |
| 2026-04-06 | Buy Back of Shares |
| 2026-02-09 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-08-04 | Quarterly Results & Interim Dividend |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
| 2024-08-10 | Quarterly Results |
Aurobindo Pharma News
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Aurobindo Pharma will engage with investors and analysts at the Motilal Oswal 22nd Annual Global Investor Conference on August 19, 2026. The company confirmed no unpublished price sensitive information will be discussed.
Aug 14 2026 16:31:22
Aurobindo Pharma Ltd - 524804 - Unit I Of Eugia Pharma Specialities Ltd. Received A Warning Letter From US FDA
Aurobindo Pharma's wholly-owned subsidiary, Eugia Pharma Specialities Ltd., received a US FDA Warning Letter for its Unit I formulation manufacturing facility. This action follows a prior Official Action Indicated (OAI) status from the FDA. The company noted no impact on existing US market supplies from this unit, which contributes ~2% to overall group revenue.
Aug 14 2026 09:41:32
Read More
Aurobindo Pharma Management
| Name | Position |
|---|---|
| Mangalam Ramasubramanian Kumar | Chairman |
| K Nityananda Reddy | Vice Chairman & Managing Director |
Aurobindo Pharma Similar Stocks
Lupin Ltd.
2235.00
-15.30 (0.68%)
Dr. Reddy's Laboratories Ltd.
1200.00
-6.00 (0.50%)
Mankind Pharma Ltd.
2425.20
20.80 (0.87%)
Laurus Labs Ltd.
1787.30
-64.40 (3.48%)
Max Healthcare Institute Ltd.
1008.60
-4.70 (0.46%)
Manipal Health Enterprises Ltd.
706.95
11.65 (1.68%)
Aster DM Quality Care Ltd.
822.35
-1.95 (0.24%)
Fortis Healthcare Ltd.
929.00
22.85 (2.52%)
Biocon Ltd.
417.00
-3.00 (0.71%)
Alkem Laboratories Ltd.
5368.00
-81.50 (1.50%)
Aurobindo Pharma FAQs
The Buying Price of Aurobindo Pharma share is 1622.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aurobindo Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aurobindo Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aurobindo Pharma shares is 25.67. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aurobindo Pharma shares is 2.45. Useful to assess the stock's value relative to its book value.
To assess Aurobindo Pharma’s valuation compare Sector P/E, P/B which are 64.91 & 3.33 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aurobindo Pharma is 93332.05 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aurobindo Pharma share price is 1682.40 & 1016.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aurobindo Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in AUROPHARMA
Or Download Choice FinX App
Invest in AUROPHARMA
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade